BRAF and colorectal carcinoma: With regard to the molecular mechanism of the OBP-702–mediated cytopathic effect against BRAF-mutant CRC cells, our data showed that OBP-702 suppresses the expression of mTOR protein in BRAF-mutant CRC cells.